115 related articles for article (PubMed ID: 16864167)
1. Clinical presentation and surgical quality in treatment of ductal carcinoma in situ of the breast.
Schouten van der Velden AP; Peeters PH; Koot VC; Hennipman A
Acta Oncol; 2006; 45(5):544-9. PubMed ID: 16864167
[TBL] [Abstract][Full Text] [Related]
2. [The surgical treatment of nonpalpable breast carcinoma in a university teaching hospital and a general teaching hospital by residents-in-training and surgeons; comparable results].
Landheer ML; Hoorntje LE; Klinkenbijl JH; Borel Rinkes IH
Ned Tijdschr Geneeskd; 2004 Aug; 148(35):1724-7. PubMed ID: 15468902
[TBL] [Abstract][Full Text] [Related]
3. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
4. Variations in treatment of ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.
Schouten van der Velden AP; Van Dijck JA; Wobbes T
Eur J Surg Oncol; 2007 May; 33(4):424-9. PubMed ID: 17084060
[TBL] [Abstract][Full Text] [Related]
5. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.
Monteau A; Sigal-Zafrani B; Kirova YM; Fourchotte V; Bollet MA; Vincent-Salomon A; Asselain B; Salmon RJ; Fourquet A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1021-8. PubMed ID: 19386441
[TBL] [Abstract][Full Text] [Related]
6. Are many community hospitals undertreating breast cancer?: lessons from 24,834 patients.
Gutierrez JC; Hurley JD; Housri N; Perez EA; Byrne MM; Koniaris LG
Ann Surg; 2008 Aug; 248(2):154-62. PubMed ID: 18650623
[TBL] [Abstract][Full Text] [Related]
7. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
Cabioglu N; Hunt KK; Sahin AA; Kuerer HM; Babiera GV; Singletary SE; Whitman GJ; Ross MI; Ames FC; Feig BW; Buchholz TA; Meric-Bernstam F
Ann Surg Oncol; 2007 Apr; 14(4):1458-71. PubMed ID: 17260108
[TBL] [Abstract][Full Text] [Related]
8. Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.
Yen TW; Kuerer HM; Ottesen RA; Rouse L; Niland JC; Edge SB; Theriault RL; Weeks JC
J Clin Oncol; 2007 Aug; 25(22):3251-8. PubMed ID: 17577019
[TBL] [Abstract][Full Text] [Related]
9. Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?
Yerushalmi R; Sulkes A; Mishaeli M; Neumann A; Dinerman M; Sulkes J; Rizel S; Yarom N; Gutman H; Fenig E
Neoplasma; 2006; 53(6):507-10. PubMed ID: 17167720
[TBL] [Abstract][Full Text] [Related]
10. Variation between hospitals in surgical margins after first breast-conserving surgery in the Netherlands.
van der Heiden-van der Loo M; de Munck L; Visser O; Westenend PJ; van Dalen T; Menke MB; Rutgers EJ; Peeters PH
Breast Cancer Res Treat; 2012 Jan; 131(2):691-8. PubMed ID: 21987038
[TBL] [Abstract][Full Text] [Related]
11. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.
Olson TP; Harter J; Muñoz A; Mahvi DM; Breslin T
Ann Surg Oncol; 2007 Oct; 14(10):2953-60. PubMed ID: 17674109
[TBL] [Abstract][Full Text] [Related]
12. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?
Valdes EK; Boolbol SK; Cohen JM; Feldman SM
Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481
[TBL] [Abstract][Full Text] [Related]
13. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
Tuttle TM; Jarosek S; Habermann EB; Arrington A; Abraham A; Morris TJ; Virnig BA
J Clin Oncol; 2009 Mar; 27(9):1362-7. PubMed ID: 19224844
[TBL] [Abstract][Full Text] [Related]
14. Predictors of surgical margin status in breast-conserving surgery within a breast screening program.
Kurniawan ED; Wong MH; Windle I; Rose A; Mou A; Buchanan M; Collins JP; Miller JA; Gruen RL; Mann GB
Ann Surg Oncol; 2008 Sep; 15(9):2542-9. PubMed ID: 18618180
[TBL] [Abstract][Full Text] [Related]
15. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
16. Ductal carcinoma in situ of the breast in Israeli women treated by breast-conserving surgery followed by radiation therapy.
Jiveliouk I; Corn B; Inbar M; Merimsky O
Oncology; 2009; 76(1):30-5. PubMed ID: 19033713
[TBL] [Abstract][Full Text] [Related]
17. Residual disease after re-excision for tumour-positive surgical margins in both ductal carcinoma in situ and invasive carcinoma of the breast: The effect of time.
Schouten van der Velden AP; Van de Vrande SL; Boetes C; Bult P; Wobbes T
J Surg Oncol; 2007 Dec; 96(7):569-74. PubMed ID: 17680635
[TBL] [Abstract][Full Text] [Related]
18. Urban-rural differences in the management of screen-detected invasive breast cancer and ductal carcinoma in situ in victoria.
Kok DL; Chang JH; Erbas B; Fletcher A; Kavanagh AM; Henderson MA; Gertig DM
ANZ J Surg; 2006 Nov; 76(11):996-1001. PubMed ID: 17054549
[TBL] [Abstract][Full Text] [Related]
19. Paget's disease of the nipple in a population based cohort.
Dalberg K; Hellborg H; Wärnberg F
Breast Cancer Res Treat; 2008 Sep; 111(2):313-9. PubMed ID: 17952590
[TBL] [Abstract][Full Text] [Related]
20. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]